Open original FDA record ↗Recall record
- FDA identifier
- Z-1451-2020
- Company in FDA record
- BioFire Diagnostics, LLC
- FDA record creation date
- Mar 6, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Complaints have been received concerning elevated rates of false negative results while using the Gastrointestinal (GI) Panel. False negative results may lead to incorrect treatment being provided which could potentially lead to more serious health events.
Source facts
- Action
- on August 8, 2019, a "Urgent: Medical Device Recall (Removal)" letter was sent to all affected consignees via FedEx priority-overnight. The notification informed consignees about the recall and asked they take the following actions: Requested Actions: " Please immediately examine your inventory for BioFire GI Panel reagents with kit lot number 0537319. The lot number can be found on the product label outside of the reagent box. " If reagents with the related kit lot number are found, please stop using the affected product, quarantine them, and call BioFire Technical Support to have the product returned. The BioFire Technical Support Team can assist with shipping logistics and provide a replacement. " Complete and return the enclosed Acknowledgement of Receipt Form as soon as possible and return to BioFire via one of the methods listed on the form. " If you have any questions or concerns, please dont hesitate to contact our customer support department at support@biofiredx.com or via telephone by dialing 1.800.735.6544 and selecting option 5 for product technical support.
- Initiated
- 2019-08-08
- Root cause
- Employee error
- Terminated
- 2022-04-12
- Distribution
- US: KY, IL, NJ, MS
- Recall number
- Z-1451-2020
- Recall status
- Terminated
- CDRH record ID
- 179484
- FDA record created
- 2020-03-06
- Recall event number
- 84825